Assignee
DENDREON CORP
43 granted patents·6 pending applications·994 citations·filing 1993–2015
Top patents by PatentIndex Score
49 records- 0197US7012066B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Mar 14, 2006·176 cites·64 claims
- 0296US6080409AImmunostimulatory methodDENDREON CORP·Filed 1995·Granted Jun 27, 2000·152 cites·7 claims
- 0395US7329640B2Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitorDENDREON CORP·Filed 2006·Granted Feb 12, 2008·16 cites·15 claims
- 0495US7169760B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Jan 30, 2007·88 cites·30 claims
- 0595US6416958B2Selective apoptosis of neoplastic cells by an HLA-DR specific monoclonal antibodyDENDREON CORP·Filed 2001·Granted Jul 9, 2002·79 cites·5 claims
- 0694US7244721B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2002·Granted Jul 17, 2007·80 cites·67 claims
- 0789US7414108B2Composition and method for producing an immune response against tumor-related antigensDENDREON CORP·Filed 2004·Granted Aug 19, 2008·29 cites·6 claims
- 0887US6210662B1Immunostimulatory compositionDENDREON CORP·Filed 1999·Granted Apr 3, 2001·47 cites·3 claims
- 0986US5976546AImmunostimulatory compositionsDENDREON CORP·Filed 1998·Granted Nov 2, 1999·58 cites·2 claims
- 1085US7700341B2Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereonDENDREON CORP·Filed 2001·Granted Apr 20, 2010·18 cites·38 claims
- 1183US7597894B2Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious diseaseDENDREON CORP·Filed 2004·Granted Oct 6, 2009·10 cites·3 claims
- 1283US7060279B2Compositions and methods for dendritic cell-based immunotherapyDENDREON CORP·Filed 2001·Granted Jun 13, 2006·10 cites·5 claims
- 1383US6194152B1Prostate tumor polynucleotide compositions and methods of detection thereofDENDREON CORP·Filed 1998·Granted Feb 27, 2001·53 cites·7 claims
- 1480US7132398B2Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitorDENDREON CORP·Filed 2003·Granted Nov 7, 2006·7 cites·36 claims
- 1578US7772266B2Small-molecule modulators of TRP-P8 activityDENDREON CORP·Filed 2007·Granted Aug 10, 2010·3 cites·21 claims
- 1678US7172892B2Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereonDENDREON CORP·Filed 2002·Granted Feb 6, 2007·11 cites·30 claims
- 1778US7112430B2Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereonDENDREON CORP·Filed 2002·Granted Sep 26, 2006·11 cites·43 claims
- 1877US7888092B2Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereonDENDREON CORP·Filed 2009·Granted Feb 15, 2011·1 cites·21 claims
- 1976US7741355B2Small-molecule modulators of TRP-p8 activityDENDREON CORP·Filed 2007·Granted Jun 22, 2010·2 cites·9 claims
- 2075US7659117B2Compositions and methods for dendritic cell-based immunotherapyDENDREON CORP·Filed 2005·Granted Feb 9, 2010·1 cites·3 claims
- 2172US7105333B2Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereonDENDREON CORP·Filed 2002·Granted Sep 12, 2006·6 cites·44 claims
- 2271US7019019B2Matriptase inhibitors and methods of useDENDREON CORP·Filed 2003·Granted Mar 28, 2006·6 cites·42 claims
- 2369US7157596B2Inhibitors of serine protease activity of matriptase or MTSP1DENDREON CORP·Filed 2002·Granted Jan 2, 2007·2 cites·31 claims
- 2467US8362264B2Compositions and methods for the treatment of disease associated with Trp-p8 expressionDENDREON CORP·Filed 2004·Granted Jan 29, 2013·2 cites·3 claims
- 2567US6015843AProcess for making silanized colloidal silicaDENDREON CORP·Filed 1998·Granted Jan 18, 2000·22 cites·10 claims
- 2664US7276364B1Nucleic acids encoding endotheliases, endotheliases and uses thereofDENDREON CORP·Filed 2000·Granted Oct 2, 2007·2 cites·32 claims
- 2759US6197579B1Cell washing device and methodDENDREON CORP·Filed 1998·Granted Mar 6, 2001·42 cites·18 claims
- 2858US7972602B2Promiscuous HER-2/Neu CD4 T cell epitopesDENDREON CORP·Filed 2007·Granted Jul 5, 2011·0 cites·15 claims
- 2957US8361479B2Promiscuous PAP CD4 T cell epitopesDENDREON CORP·Filed 2007·Granted Jan 29, 2013·0 cites·18 claims
- 3057US2006205672A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2005·Application pending·0 cites
- 3157US2013190296A1Compositions and methods for the treatment of disease associated with trp-p8 expressionDENDREON CORP·Filed 2012·Application pending·0 cites
- 3255US7560104B2Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentationDENDREON CORP·Filed 2006·Granted Jul 14, 2009·0 cites·5 claims
- 3354US6121044APotent antigen presenting cell compositionDENDREON CORP·Filed 1995·Granted Sep 19, 2000·16 cites·7 claims
- 3453US2004161413A1Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancersDENDREON CORP·Filed 2003·Application pending·0 cites
- 3553US2005059606A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2004·Application pending·0 cites
- 3652US8354507B2HLA-DR specific antibodies, compositions and methodsDENDREON CORP·Filed 2004·Granted Jan 15, 2013·0 cites·7 claims
- 3752US7413869B2Method for determining potency of antigenic presenting cell based vaccinesDENDREON CORP·Filed 2002·Granted Aug 19, 2008·2 cites·10 claims
- 3851US8647865B2Promiscuous PAP CD4 T cell epitopesDENDREON CORP·Filed 2013·Granted Feb 11, 2014·0 cites·10 claims
- 3950US2015266810A1Compositions and methods for the treatment of disease associated with trp-p8 expressionDENDREON CORP·Filed 2015·Application pending·0 cites
- 4048US10261091B2Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with improved clinical outcomeDENDREON CORP·Filed 2014·Granted Apr 16, 2019·0 cites·11 claims
- 4147US7279309B2Process for manufacture of Nematode-extracted Anticoagulant Protein (NAP)DENDREON CORP·Filed 2005·Granted Oct 9, 2007·0 cites·25 claims
- 4247US5998599AGrowth arrest gene compositions and methodsDENDREON CORP·Filed 1997·Granted Dec 7, 1999·4 cites·8 claims
- 4346US2008221026A1Process for manufacture of nematode-extracted anticoagulant protein (NAP)DENDREON CORP·Filed 2007·Application pending·0 cites
- 4445US7125703B2Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereonDENDREON CORP·Filed 2002·Granted Oct 24, 2006·6 cites·36 claims
- 4545US5789148ACell separation compositionDENDREON CORP·Filed 1995·Granted Aug 4, 1998·26 cites·8 claims
- 4639US7262211B2Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formationDENDREON CORP·Filed 2002·Granted Aug 28, 2007·0 cites·19 claims
- 4735US6787612B1Resin derivatization method and uses thereofDENDREON CORP·Filed 1998·Granted Sep 7, 2004·4 cites·16 claims
- 4834US7148324B1Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentationDENDREON CORP·Filed 1999·Granted Dec 12, 2006·1 cites·4 claims
- 4933US6962795B1Neutrophil inhibitorsDENDREON CORP·Filed 1993·Granted Nov 8, 2005·1 cites·142 claims
Join the waitlist — get patent alerts
Get an alert when DENDREON CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →